US2004228933A1PendingUtilityA1

Method for normalizing insulin levels

Priority: Oct 26, 2001Filed: Jun 15, 2004Published: Nov 18, 2004
Est. expiryOct 26, 2021(expired)· nominal 20-yr term from priority
A61K 31/7012A61K 31/198
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The dietary supplement may also include one or more amino acids.

Claims

exact text as granted — not AI-modified
1 . A solid oral dosage form to be swallowed, wherein said dosage form comprises mannoheptulose and a controlled release system.  
     
     
         2 . The oral dosage form of  claim 1 , wherein said controlled release system is a delayed release system.  
     
     
         3 . The oral dosage form of  claim 1 , wherein said controlled release system is a sustained release system.  
     
     
         4 . The oral dosage form of  claim 1 , wherein said controlled release system comprises carboxymethylcellulose.  
     
     
         5 . A solid oral dosage form to be swallowed, wherein said oral dosage form comprises mannoheptulose, a controlled release system, and one or more amino acids.  
     
     
         6 . The oral dosage form of  claim 5 , wherein one amino acid is glutamic acid.  
     
     
         7 . The oral dosage form of  claim 5 , wherein one amino acid is aspartic acid.  
     
     
         8 . The oral dosage form of any one of claims  1 - 7 , wherein said oral dosage form comprises 10 mg-1000 mg of mannoheptulose.  
     
     
         9 . The oral dosage form of any one of claims  1 - 7 , wherein said oral dosage form comprises 50 mg-250 mg of mannoheptulose.  
     
     
         10 . (canceled)  
     
     
         11 . (canceled)  
     
     
         12 . (canceled)  
     
     
         13 . (canceled)  
     
     
         14 . (canceled)

Join the waitlist — get patent alerts

Track US2004228933A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.